Global Female Oral Contraceptives Market Research Report 2023

Publisher Name :
Date: 13-Jan-2023
No. of pages: 99
Inquire Before Buying

Highlights

The global Female Oral Contraceptives market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Female Oral Contraceptives is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Female Oral Contraceptives is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Female Oral Contraceptives include Bayer, Janssen Global Services, Allergan,plc (Actavis), Teva Pharmaceutical, Piramal Enterprises, Pfizer, Merck, Mankind Pharma and Syzygy Healthcare, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Female Oral Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Oral Contraceptives.

The Female Oral Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Female Oral Contraceptives market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Female Oral Contraceptives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Bayer

- Janssen Global Services

- Allergan,plc (Actavis)

- Teva Pharmaceutical

- Piramal Enterprises

- Pfizer

- Merck

- Mankind Pharma

- Syzygy Healthcare

- Ferring B.V

Segment by Type

- Combination Pill

- Progestin-only Pill

- Continuous Use Pill

Segment by Application

- Online Sales

- Offline Sales

Consumption by Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Southeast Asia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Colombia

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Female Oral Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Female Oral Contraceptives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Female Oral Contraceptives Market Research Report 2023

Table of Contents
1 Female Oral Contraceptives Market Overview
1.1 Product Overview and Scope of Female Oral Contraceptives
1.2 Female Oral Contraceptives Segment by Type
1.2.1 Global Female Oral Contraceptives Market Value Comparison by Type (2023-2029)
1.2.2 Combination Pill
1.2.3 Progestin-only Pill
1.2.4 Continuous Use Pill
1.3 Female Oral Contraceptives Segment by Application
1.3.1 Global Female Oral Contraceptives Market Value by Application: (2023-2029)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Female Oral Contraceptives Market Size Estimates and Forecasts
1.4.1 Global Female Oral Contraceptives Revenue 2018-2029
1.4.2 Global Female Oral Contraceptives Sales 2018-2029
1.4.3 Global Female Oral Contraceptives Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Female Oral Contraceptives Market Competition by Manufacturers
2.1 Global Female Oral Contraceptives Sales Market Share by Manufacturers (2018-2023)
2.2 Global Female Oral Contraceptives Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Female Oral Contraceptives Average Price by Manufacturers (2018-2023)
2.4 Global Female Oral Contraceptives Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Female Oral Contraceptives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Female Oral Contraceptives, Product Type & Application
2.7 Female Oral Contraceptives Market Competitive Situation and Trends
2.7.1 Female Oral Contraceptives Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Female Oral Contraceptives Players Market Share by Revenue
2.7.3 Global Female Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Female Oral Contraceptives Retrospective Market Scenario by Region
3.1 Global Female Oral Contraceptives Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Female Oral Contraceptives Global Female Oral Contraceptives Sales by Region: 2018-2029
3.2.1 Global Female Oral Contraceptives Sales by Region: 2018-2023
3.2.2 Global Female Oral Contraceptives Sales by Region: 2024-2029
3.3 Global Female Oral Contraceptives Global Female Oral Contraceptives Revenue by Region: 2018-2029
3.3.1 Global Female Oral Contraceptives Revenue by Region: 2018-2023
3.3.2 Global Female Oral Contraceptives Revenue by Region: 2024-2029
3.4 North America Female Oral Contraceptives Market Facts & Figures by Country
3.4.1 North America Female Oral Contraceptives Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Female Oral Contraceptives Sales by Country (2018-2029)
3.4.3 North America Female Oral Contraceptives Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Female Oral Contraceptives Market Facts & Figures by Country
3.5.1 Europe Female Oral Contraceptives Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Female Oral Contraceptives Sales by Country (2018-2029)
3.5.3 Europe Female Oral Contraceptives Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Female Oral Contraceptives Market Facts & Figures by Country
3.6.1 Asia Pacific Female Oral Contraceptives Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Female Oral Contraceptives Sales by Country (2018-2029)
3.6.3 Asia Pacific Female Oral Contraceptives Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Female Oral Contraceptives Market Facts & Figures by Country
3.7.1 Latin America Female Oral Contraceptives Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Female Oral Contraceptives Sales by Country (2018-2029)
3.7.3 Latin America Female Oral Contraceptives Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Female Oral Contraceptives Market Facts & Figures by Country
3.8.1 Middle East and Africa Female Oral Contraceptives Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Female Oral Contraceptives Sales by Country (2018-2029)
3.8.3 Middle East and Africa Female Oral Contraceptives Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Female Oral Contraceptives Sales by Type (2018-2029)
4.1.1 Global Female Oral Contraceptives Sales by Type (2018-2023)
4.1.2 Global Female Oral Contraceptives Sales by Type (2024-2029)
4.1.3 Global Female Oral Contraceptives Sales Market Share by Type (2018-2029)
4.2 Global Female Oral Contraceptives Revenue by Type (2018-2029)
4.2.1 Global Female Oral Contraceptives Revenue by Type (2018-2023)
4.2.2 Global Female Oral Contraceptives Revenue by Type (2024-2029)
4.2.3 Global Female Oral Contraceptives Revenue Market Share by Type (2018-2029)
4.3 Global Female Oral Contraceptives Price by Type (2018-2029)
5 Segment by Application
5.1 Global Female Oral Contraceptives Sales by Application (2018-2029)
5.1.1 Global Female Oral Contraceptives Sales by Application (2018-2023)
5.1.2 Global Female Oral Contraceptives Sales by Application (2024-2029)
5.1.3 Global Female Oral Contraceptives Sales Market Share by Application (2018-2029)
5.2 Global Female Oral Contraceptives Revenue by Application (2018-2029)
5.2.1 Global Female Oral Contraceptives Revenue by Application (2018-2023)
5.2.2 Global Female Oral Contraceptives Revenue by Application (2024-2029)
5.2.3 Global Female Oral Contraceptives Revenue Market Share by Application (2018-2029)
5.3 Global Female Oral Contraceptives Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Female Oral Contraceptives Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer Female Oral Contraceptives Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Janssen Global Services
6.2.1 Janssen Global Services Corporation Information
6.2.2 Janssen Global Services Description and Business Overview
6.2.3 Janssen Global Services Female Oral Contraceptives Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Janssen Global Services Female Oral Contraceptives Product Portfolio
6.2.5 Janssen Global Services Recent Developments/Updates
6.3 Allergan,plc (Actavis)
6.3.1 Allergan,plc (Actavis) Corporation Information
6.3.2 Allergan,plc (Actavis) Description and Business Overview
6.3.3 Allergan,plc (Actavis) Female Oral Contraceptives Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Allergan,plc (Actavis) Female Oral Contraceptives Product Portfolio
6.3.5 Allergan,plc (Actavis) Recent Developments/Updates
6.4 Teva Pharmaceutical
6.4.1 Teva Pharmaceutical Corporation Information
6.4.2 Teva Pharmaceutical Description and Business Overview
6.4.3 Teva Pharmaceutical Female Oral Contraceptives Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Pharmaceutical Female Oral Contraceptives Product Portfolio
6.4.5 Teva Pharmaceutical Recent Developments/Updates
6.5 Piramal Enterprises
6.5.1 Piramal Enterprises Corporation Information
6.5.2 Piramal Enterprises Description and Business Overview
6.5.3 Piramal Enterprises Female Oral Contraceptives Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Piramal Enterprises Female Oral Contraceptives Product Portfolio
6.5.5 Piramal Enterprises Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Female Oral Contraceptives Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Pfizer Female Oral Contraceptives Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Female Oral Contraceptives Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Female Oral Contraceptives Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Mankind Pharma
6.8.1 Mankind Pharma Corporation Information
6.8.2 Mankind Pharma Description and Business Overview
6.8.3 Mankind Pharma Female Oral Contraceptives Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mankind Pharma Female Oral Contraceptives Product Portfolio
6.8.5 Mankind Pharma Recent Developments/Updates
6.9 Syzygy Healthcare
6.9.1 Syzygy Healthcare Corporation Information
6.9.2 Syzygy Healthcare Description and Business Overview
6.9.3 Syzygy Healthcare Female Oral Contraceptives Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Syzygy Healthcare Female Oral Contraceptives Product Portfolio
6.9.5 Syzygy Healthcare Recent Developments/Updates
6.10 Ferring B.V
6.10.1 Ferring B.V Corporation Information
6.10.2 Ferring B.V Description and Business Overview
6.10.3 Ferring B.V Female Oral Contraceptives Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Ferring B.V Female Oral Contraceptives Product Portfolio
6.10.5 Ferring B.V Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Female Oral Contraceptives Industry Chain Analysis
7.2 Female Oral Contraceptives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Female Oral Contraceptives Production Mode & Process
7.4 Female Oral Contraceptives Sales and Marketing
7.4.1 Female Oral Contraceptives Sales Channels
7.4.2 Female Oral Contraceptives Distributors
7.5 Female Oral Contraceptives Customers
8 Female Oral Contraceptives Market Dynamics
8.1 Female Oral Contraceptives Industry Trends
8.2 Female Oral Contraceptives Market Drivers
8.3 Female Oral Contraceptives Market Challenges
8.4 Female Oral Contraceptives Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Female Oral Contraceptives Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Female Oral Contraceptives Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Female Oral Contraceptives Market Competitive Situation by Manufacturers in 2022
Table 4. Global Female Oral Contraceptives Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Female Oral Contraceptives Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Female Oral Contraceptives Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Female Oral Contraceptives Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Female Oral Contraceptives Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Female Oral Contraceptives, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Female Oral Contraceptives, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Female Oral Contraceptives, Product Type & Application
Table 12. Global Key Manufacturers of Female Oral Contraceptives, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Female Oral Contraceptives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Oral Contraceptives as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Female Oral Contraceptives Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Female Oral Contraceptives Sales by Region (2018-2023) & (K Units)
Table 18. Global Female Oral Contraceptives Sales Market Share by Region (2018-2023)
Table 19. Global Female Oral Contraceptives Sales by Region (2024-2029) & (K Units)
Table 20. Global Female Oral Contraceptives Sales Market Share by Region (2024-2029)
Table 21. Global Female Oral Contraceptives Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Female Oral Contraceptives Revenue Market Share by Region (2018-2023)
Table 23. Global Female Oral Contraceptives Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Female Oral Contraceptives Revenue Market Share by Region (2024-2029)
Table 25. North America Female Oral Contraceptives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Female Oral Contraceptives Sales by Country (2018-2023) & (K Units)
Table 27. North America Female Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 28. North America Female Oral Contraceptives Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Female Oral Contraceptives Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Female Oral Contraceptives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Female Oral Contraceptives Sales by Country (2018-2023) & (K Units)
Table 32. Europe Female Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 33. Europe Female Oral Contraceptives Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Female Oral Contraceptives Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Female Oral Contraceptives Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Female Oral Contraceptives Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Female Oral Contraceptives Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Female Oral Contraceptives Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Female Oral Contraceptives Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Female Oral Contraceptives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Female Oral Contraceptives Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Female Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Female Oral Contraceptives Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Female Oral Contraceptives Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Female Oral Contraceptives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Female Oral Contraceptives Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Female Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Female Oral Contraceptives Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Female Oral Contraceptives Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Female Oral Contraceptives Sales (K Units) by Type (2018-2023)
Table 51. Global Female Oral Contraceptives Sales (K Units) by Type (2024-2029)
Table 52. Global Female Oral Contraceptives Sales Market Share by Type (2018-2023)
Table 53. Global Female Oral Contraceptives Sales Market Share by Type (2024-2029)
Table 54. Global Female Oral Contraceptives Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Female Oral Contraceptives Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Female Oral Contraceptives Revenue Market Share by Type (2018-2023)
Table 57. Global Female Oral Contraceptives Revenue Market Share by Type (2024-2029)
Table 58. Global Female Oral Contraceptives Price (US$/Unit) by Type (2018-2023)
Table 59. Global Female Oral Contraceptives Price (US$/Unit) by Type (2024-2029)
Table 60. Global Female Oral Contraceptives Sales (K Units) by Application (2018-2023)
Table 61. Global Female Oral Contraceptives Sales (K Units) by Application (2024-2029)
Table 62. Global Female Oral Contraceptives Sales Market Share by Application (2018-2023)
Table 63. Global Female Oral Contraceptives Sales Market Share by Application (2024-2029)
Table 64. Global Female Oral Contraceptives Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Female Oral Contraceptives Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Female Oral Contraceptives Revenue Market Share by Application (2018-2023)
Table 67. Global Female Oral Contraceptives Revenue Market Share by Application (2024-2029)
Table 68. Global Female Oral Contraceptives Price (US$/Unit) by Application (2018-2023)
Table 69. Global Female Oral Contraceptives Price (US$/Unit) by Application (2024-2029)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Bayer Female Oral Contraceptives Product
Table 74. Bayer Recent Developments/Updates
Table 75. Janssen Global Services Corporation Information
Table 76. Janssen Global Services Description and Business Overview
Table 77. Janssen Global Services Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Janssen Global Services Female Oral Contraceptives Product
Table 79. Janssen Global Services Recent Developments/Updates
Table 80. Allergan,plc (Actavis) Corporation Information
Table 81. Allergan,plc (Actavis) Description and Business Overview
Table 82. Allergan,plc (Actavis) Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Allergan,plc (Actavis) Female Oral Contraceptives Product
Table 84. Allergan,plc (Actavis) Recent Developments/Updates
Table 85. Teva Pharmaceutical Corporation Information
Table 86. Teva Pharmaceutical Description and Business Overview
Table 87. Teva Pharmaceutical Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Teva Pharmaceutical Female Oral Contraceptives Product
Table 89. Teva Pharmaceutical Recent Developments/Updates
Table 90. Piramal Enterprises Corporation Information
Table 91. Piramal Enterprises Description and Business Overview
Table 92. Piramal Enterprises Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Piramal Enterprises Female Oral Contraceptives Product
Table 94. Piramal Enterprises Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Pfizer Female Oral Contraceptives Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Merck Corporation Information
Table 101. Merck Description and Business Overview
Table 102. Merck Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Merck Female Oral Contraceptives Product
Table 104. Merck Recent Developments/Updates
Table 105. Mankind Pharma Corporation Information
Table 106. Mankind Pharma Description and Business Overview
Table 107. Mankind Pharma Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Mankind Pharma Female Oral Contraceptives Product
Table 109. Mankind Pharma Recent Developments/Updates
Table 110. Syzygy Healthcare Corporation Information
Table 111. Syzygy Healthcare Description and Business Overview
Table 112. Syzygy Healthcare Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Syzygy Healthcare Female Oral Contraceptives Product
Table 114. Syzygy Healthcare Recent Developments/Updates
Table 115. Ferring B.V Corporation Information
Table 116. Ferring B.V Description and Business Overview
Table 117. Ferring B.V Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Ferring B.V Female Oral Contraceptives Product
Table 119. Ferring B.V Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Female Oral Contraceptives Distributors List
Table 123. Female Oral Contraceptives Customers List
Table 124. Female Oral Contraceptives Market Trends
Table 125. Female Oral Contraceptives Market Drivers
Table 126. Female Oral Contraceptives Market Challenges
Table 127. Female Oral Contraceptives Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Female Oral Contraceptives
Figure 2. Global Female Oral Contraceptives Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Female Oral Contraceptives Market Share by Type in 2022 & 2029
Figure 4. Combination Pill Product Picture
Figure 5. Progestin-only Pill Product Picture
Figure 6. Continuous Use Pill Product Picture
Figure 7. Global Female Oral Contraceptives Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Female Oral Contraceptives Market Share by Application in 2022 & 2029
Figure 9. Online Sales
Figure 10. Offline Sales
Figure 11. Global Female Oral Contraceptives Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Female Oral Contraceptives Market Size (2018-2029) & (US$ Million)
Figure 13. Global Female Oral Contraceptives Sales (2018-2029) & (K Units)
Figure 14. Global Female Oral Contraceptives Average Price (US$/Unit) & (2018-2029)
Figure 15. Female Oral Contraceptives Report Years Considered
Figure 16. Female Oral Contraceptives Sales Share by Manufacturers in 2022
Figure 17. Global Female Oral Contraceptives Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Female Oral Contraceptives Players: Market Share by Revenue in 2022
Figure 19. Female Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Female Oral Contraceptives Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Female Oral Contraceptives Sales Market Share by Country (2018-2029)
Figure 22. North America Female Oral Contraceptives Revenue Market Share by Country (2018-2029)
Figure 23. United States Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Female Oral Contraceptives Sales Market Share by Country (2018-2029)
Figure 26. Europe Female Oral Contraceptives Revenue Market Share by Country (2018-2029)
Figure 27. Germany Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Female Oral Contraceptives Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Female Oral Contraceptives Revenue Market Share by Region (2018-2029)
Figure 34. China Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Female Oral Contraceptives Sales Market Share by Country (2018-2029)
Figure 42. Latin America Female Oral Contraceptives Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Female Oral Contraceptives Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Female Oral Contraceptives Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Female Oral Contraceptives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Female Oral Contraceptives by Type (2018-2029)
Figure 53. Global Revenue Market Share of Female Oral Contraceptives by Type (2018-2029)
Figure 54. Global Female Oral Contraceptives Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Female Oral Contraceptives by Application (2018-2029)
Figure 56. Global Revenue Market Share of Female Oral Contraceptives by Application (2018-2029)
Figure 57. Global Female Oral Contraceptives Price (US$/Unit) by Application (2018-2029)
Figure 58. Female Oral Contraceptives Value Chain
Figure 59. Female Oral Contraceptives Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs